Gregory P. Hess, MD, MSc, MBA
He / Him / His / Himself
Lecturer
Contact
901 Walnut Street, 10th Floor
Philadelphia , PA 19107
Gregory P. Hess, MD, MSc, MBA
He / Him / His / Himself
Lecturer
Research & Practice Interests
Health Economics
Epidemiology
Outcomes Research
Kidney Transplant
Design, Construction & Implementation of Real-World Integrated Patient-Level Platforms
Education
MD, Albany Medical College
MSc, Erasmus University, Netherlands
MBA, The Wharton School of the University of Pennsylvania
Publications
- Gabapentin, Concomitant Prescription of Opioids, and Benzodiazepines among Kidney Transplant Recipients
- Registry-based cohort study of alpha-1 antitrypsin deficiency prevalence, incidence and mortality in Denmark 2000-2018
- Kidney Transplantation, Immunosuppression and the Risk of Fracture: Clinical and Economic Implications
- Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients
- Effect of Early Steroid Withdrawal on Posttransplant Diabetes among Kidney Transplant Recipients Differs by Recipient Age
Certifications
American Board of Emergency Medicine
Advanced Trauma Life Support Instructor
BIOGRAPHY
Dr. Hess is cross-trained and experienced as a global business executive in the pharmaceutical industry; in academia with a series of appointments at US and international universities; as a real-world data expert and researcher designing multiple US wide integrated patient platforms and studies; and health policy advocate for the National Kidney Foundation and other organizations. He is a practicing clinician and also serves as a Physician Advisor for the American Society of Clinical Oncology (ASCO) CancerLinQ, and various pharmaceutical and biotech companies. He enjoys collaborating on a broad range of health economic, epidemiologic and outcomes studies, and the design and creation of integrated data platforms to enable such studies. Prior studies include those with the Scientific Registry of Transplant Recipients (SRTR), the American College of Cardiology (ACC), cancer registries, the National Institute of Health (NIH) and other professional societies and organizations.